T 1742/21 (FGFR3 fusion/ASTELLAS PHARMA) of 16.03.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T174221.20230316
- Date of decision
- 16 March 2023
- Case number
- T 1742/21
- Petition for review of
- -
- Application number
- 13757006.5
- IPC class
- C12Q 1/6886
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Novel FGFR3 fusion product
- Applicant name
- Astellas Pharma Inc.
- Opponent name
- James Poole Limited
Boult Wade Tennant LLP - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 84Rules of procedure of the Boards of Appeal 2020 Art 012(2)Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Main request and auxiliary requests 1 to 7 - claims - clarity (no)
Auxiliary requests 8 and 9 - amendement to case - admitted (no) - Catchword
- -
- Cited cases
- J 0014/19
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.